65,437 trials
Hypercholesterolemia
Primary: Percent Change From Baseline in LDL-Cholesterol (mg/dL) After 6 Weeks of Treatment — -21.57; -5.58 percent change — p=<0.001
Osteoporosis
Primary: Number of Participants With Serious Adverse Events — 0 Participants
Hypertension
Primary: Change From Baseline in Mean Seated Systolic Blood Pressure (SBP) Following 12 Weeks of Treatment With PS433540 200 mg, 400 mg, 800 mg and Placebo. — -10.7; 1.8; -13.2…
Cerebral Palsy · Developmental Delay
Primary: Ankle Passive Range of Motion — 8.3; 10.4 degree
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (A1C) at Week 24 — -1.02; -0.14 Percent — p=<.001
Meningococcal Disease · Meningococcal Meningitis
Primary: Percentage of Participants With Serum Bactericidal Activity >=8 at 5 Years After Primary Vaccination — 30; 44; 11; 76 Percentage of participants
Diabetes Mellitus, Non-Insulin-Dependent
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) at Week 12 — -0.76; 0.16 Percentage of glycosylated hemoglobin — p=<.001
Moderate to Severe Glabellar Frown Lines
Primary: Composite Endpoint Treatment Success (CETS) Constituted by 2 Variables: 2-point Responders at Maximum Frown (Frown as Much as Possible) at Day 30 by Investigator's…
Pain
Primary: Patient's Perception of Pain Using the Wong-Baker FACES Visual Scale: 0 - no Pain; 5 - Worst Imaginable Pain — 1; 2 Scores on a scale — p=<0.001
Hypertension
Primary: Number of Participants With Macroalbuminuria After 6 Months of Treatment — 7; 6 participants
Myocardial Infarction
Primary: Bleeding Time — 1020; 1020 seconds
Moderate to Severe Glabellar Frown Lines
Primary: Composite Endpoint Treatment Success (CETS) Constituted by 2 Variables: 2-point Responders at Maximum Frown (Frown as Much as Possible) at Day 30 by Investigator's…
Orthomyxoviridae Infection · Influenza · Myxovirus Infection
Primary: Number of Participants With at Least a 4-Fold Increase in Serum HAI Antibody Titer Post-vaccination With Either Fluzone Intradermal or Fluzone Intramuscular Vaccine…
Leukopenia
Primary: Number of Participants With Proven or Probable Diagnosis of Invasive Fungal Infection (IFI) During the Treatment Period — 4; 11 participants
Open-angle Glaucoma · Ocular Hypertension
Primary: Mean Intraocular Pressure (IOP) Change From Baseline at All 9 Time Points During the Study (0800, 1000 and 1600 Hrs at Weeks 2, 6, and 12) — -7.1; -6.8; -6.8; -6.1 mmHg